Bridgebio Pharma, Inc. · NASDAQ:BBIO

Viking Global Investors LP reported a 11.70% stake in Bridgebio Pharma, Inc. (Schedule 13D/A)

Event Jan 31, 2025 · Filed Mar 12, 2025

Viking Global Investors LP reported a 11.70% stake in Bridgebio Pharma, Inc., 22,055,375 shares, with active intent on Jan 31, 2025. Filed Mar 12, 2025 (Schedule 13D/A).

Stake
11.70%
Shares
22,055,375
Intent
Active
What changed
Stake changed
Filed together
12 holders

The filing in full

HolderStakeShares
VIKING GLOBAL INVESTORS LP11.70%22,055,375
VIKING GLOBAL PERFORMANCE LLC0.30%487,901
Viking Global Equities Master Ltd.0.30%487,901
Viking Long Fund GP LLC0.10%194,184
Viking Long Fund Master Ltd.0.10%194,184
Viking Global Opportunities Parent GP LLC11.30%21,373,290
Viking Global Opportunities GP LLC11.30%21,373,290
Viking Global Opportunities Portfolio GP LLC11.30%21,373,290
Viking Global Opportunities Illiquid Investments Sub-Master LP11.30%21,373,290
HALVORSEN OLE ANDREAS11.70%22,055,375
Ott David C.11.70%22,055,375
Shabet Rose Sharon11.70%22,055,375

Source

View original at SEC

Related